KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$58.60
+1.67 (+2.93%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+24.0% upside
Low Target
$47.11
Average Target
$72.69
High Target
$100.82
Current Price
$58.60
Current
$58.60
$58.60
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Scenario Analysis
Bear Case
$47.11
-19.6%
Low target
Base Case
$72.69
+24.0%
Avg target
Bull Case
$100.82
+72.0%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$58.26
0.6% from high
52-Week Low
$24.85
+135.8% from low
50-Day SMA
$42.51
+37.8% vs SMA
200-Day SMA
$35.71
+64.1% vs SMA
RSI (14)
68.7
Neutral
Target vs 52W High
$72.69
+24.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 72% | $257.58 | +27.8% |
| AMGN | Hold | 43 | 49% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 26 | 96% | $143.40 | +41.5% |